Try for free

C61 ICD-10-CM Code: Malignant neoplasm of prostate

A clear reference for the official code description, hierarchy, and related coding information from the FY 2027 U.S. release.

Official description

C61

Malignant neoplasm of prostate

ICD-10-CM diagnosis code · United States clinical modification

Where C61 sits

  1. 1

    Chapter 2

    Neoplasms (C00-D49)

  2. 2

    Section

    Malignant neoplasms of male genital organs (C60-C63)

  3. 3

    Category C61

    Malignant neoplasm of prostate

  4. 4

    Code C61

    Malignant neoplasm of prostate

Notes for this code

Inclusion terms

No inclusion terms are listed for C61.

Code first

No “code first” instruction is listed for C61.

Use additional code

  • code, if applicable, to identify:
  • hormone sensitivity status (Z19.1-Z19.2)
  • rising PSA following treatment for malignant neoplasm of prostate (R97.21)

Excludes1

Conditions that should not be reported together with this code.

  • malignant neoplasm of seminal vesicle (C63.7)

Excludes2

Conditions not included here that may be reported separately when present.

No Excludes2 note is listed for C61.

Source and release

Data release
U.S. ICD-10-CM · FY 2027
Effective date
Oct 1, 2026

This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.

Review the CDC/NCHS ICD-10-CM source

Frequently asked questions

What does ICD-10-CM code C61 mean?

C61 is the FY 2027 U.S. ICD-10-CM code for “Malignant neoplasm of prostate.”

Is C61 a billable or specific ICD-10-CM code?

Yes. In the FY 2027 reference data used on this page, C61 has no child codes and is presented as a billable/specific code. Always confirm the active code set and payer requirements before use.

Where is C61 located in ICD-10-CM?

C61 is listed in Chapter 2, Neoplasms (C00-D49), within Malignant neoplasms of male genital organs (C60-C63) (C60–C63), under category C61, Malignant neoplasm of prostate.

What coding notes are listed for C61?

No inclusion terms are listed for C61 in this reference record. No code-first instruction is listed. Additional-code instructions: code, if applicable, to identify:; hormone sensitivity status (Z19.1-Z19.2); rising PSA following treatment for malignant neoplasm of prostate (R97.21). Excludes1 notes: malignant neoplasm of seminal vesicle (C63.7). No Excludes2 note is listed.